Stocktoria

Tyra Biosciences, Inc. TYRA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-09-15

Tyra Biosciences, Inc. statistics & valuation

Market cap$1.9B
P / B7.3×
Return on equity-46.3%
Return on capital-50.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-8.70% -21.50% -33.80% -25.20% -46.30% 202020212022202320242025
Shares outstanding
1.8M 41.4M 42.4M 43.0M 57.2M 59.6M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-58.30% -8.60% -20.80% -30.60% -23.80% -42.40% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.91 -$1.32 -$1.62 -$1.51 -$2.01 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-42.4%-23.8%-30.6%-20.8%-8.6%-58.3%
Return on equity-46.3%-25.2%-33.8%-21.5%-8.7%68.5%
Current ratio14.6723.8113.8045.1384.098.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.